Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study

A snapshot of cancer-associated thromboembolic disease in 2018–2019: First data from the TESEO prospective registry

(2020) Alberto Carmona-Bayonas et al.   European Journal of Internal Medicine

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

(2020) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

(2019) Stavros V Konstantinides et al.   EUROPEAN HEART JOURNAL

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

(2019) Nigel S. Key et al.   JOURNAL OF CLINICAL ONCOLOGY

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

(2019) Dominique Farge et al.   LANCET ONCOLOGY

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

(2018) Annie M. Young et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH

(2018) A. A. Khorana et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

(2018) Gary E. Raskob et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

(2018) Marcello Di Nisio et al.   THROMBOSIS AND HAEMOSTASIS

Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study

(2018) Cecilia Becattini et al.   THROMBOSIS AND HAEMOSTASIS

NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018

(2018) Michael B. Streiff et al.   Journal of the National Comprehensive Cancer Network

Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry

(2018) Sylvia Haas et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic Therapy for VTE Disease

(2016) Clive Kearon et al.   CHEST

Controversies in the management of cancer-associated thrombosis

(2016) Marc Carrier et al.   Expert Review of Hematology

Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use

(2015) I. Martinelli et al.   BLOOD

Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

(2014) N. van Es et al.   BLOOD

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE